Advertisement

Agreement between women's and providers' assessment of hormonal contraceptive risk factors

      Objective

      To measure agreement between women's self-administered risk factor questionnaire and their providers' evaluation of their medical eligibility for hormonal contraceptive use.

      Methods

      This was an anonymous cross-sectional study. Participants were women 15���45 years old who completed a 20-item self-administered questionnaire. Women were recruited from six public health family planning clinics in the Seattle Metropolitan area. A matching medical evaluation questionnaire was completed concurrently by each participant's health care provider. Using provider evaluation as the ���gold standard��� against which we compared self-reported medical history, we calculated participant���provider agreement with point estimates and 95% confidence interval (CI).

      Results

      Of 399 participant and provider pairs, participant���provider agreement was obtained for 392 participant pairs. The majority of the participants (90.3%) were 15���30 years old and 77.7% had used a hormonal contraceptive method for more than 1 year. The estimated proportion of the overall agreement was 96% (95% CI, 0.92���0.98). Women were more likely to report severe headaches (12.4% vs. 3.3%), possible pregnancy (7.3% vs. 3.5%) and smoking (6.2% vs. 2.1%) than providers, but less likely to report smoking more than 15 cigarettes per day (2.6% vs. 9.2%) and irregular menses (6.5% vs. 9.9%).

      Conclusion

      Overall, a high proportion of the women in this study completed our medical history questionnaire in concordance with their health care providers' same-day medical evaluation. Agreement on critical medical eligibility criteria such as hypertension was well above 90%. For criteria on which there was disagreement, women were more likely to identify contraindications than were their providers.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stewart F.H.
        • Harper C.C.
        • Ellertson C.E.
        • Grimes D.A.
        • Sawaya G.F.
        • Trussell J.
        Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence.
        JAMA. 2001; 285: 2232-2239
        • World Health Organization
        Medical eligibility criteria for initiating and continuing use of contraceptive methods.
        3rd ed. WHO, Geneva (Switzerland)2004
        • Hatcher R.A.
        • Nelson A.
        Combined hormonal contraceptive methods.
        in: Trussell J. Stewart F. Nelson A. Contraceptive technology. 18th ed. Ardent Media, Inc, New York2004: 412
        • International Planned Parenthood Federation
        Medical and service delivery guidelines for sexual and reproductive health services. 3rd ed. London, United Kingdom2004: 86
        • Harper C.
        • Balistreri E.
        • Boggess J.
        • Leon K.
        • Darney P.
        Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project.
        Fam Plann Perspect. 2001; 3: 13-18
        • Stang A.
        • Schwingl P.
        • Rivera R.
        New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes.
        Bull WHO. 2000; 78: 1015-1023
        • Hannaford P.C.
        • Webb A.M.
        Evidence-guided prescribing of combined oral contraceptives: consensus statement. An International Workshop at Mottram Hall, U.K. Wilmslow, March, 1996.
        Contraception. 1996; 54: 125-129
        • Family Health International
        Provider checklists for reproductive health services: reference guide.
        (Available at:) ([Retrieved May 23, 2005])
        • Shotorbani S.
        • et al.
        Contraceptive prescribing by community pharmacists: the direct access Study.
        Contraception. 2004; 70 ([Abstract]): 258
        • Hobbs S.D.
        • Wilmink A.B.
        • Adam D.J.
        • Bradbury A.W.
        Assessment of smoking status in patients with peripheral arterial disease.
        J Vasc Surg. 2005; 4: 451-456
        • Hald J.
        • Overgaard J.
        • Grau C.
        Evaluation of objective measures of smoking status ��� a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy.
        Acta Oncol. 2003; 42: 154-159
        • Caraballo R.S.
        • Giovino G.A.
        • Pechacek T.F.
        Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents.
        Nicotine Tob Res. 2004; 6: 19-25
        • Bosetti C.
        • Tavani A.
        • Negri E.
        • Trichopoulos D.
        • La Vecchia C.
        Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls.
        J Clin Epidemiol. 2001; 54: 902-906
        • Bean J.A.
        • Leeper J.D.
        • Wallace R.B.
        • Sherman B.M.
        • Jagger H.
        Variations in the reporting of menstrual histories.
        Am J Epidemiol. 1979; 109: 181-185
        • Lipton R.B.
        • Amatniek J.C.
        • Ferrari M.D.
        • Gross M.
        Migraine. Identifying and removing barriers to care.
        Neurology. 1994; 44: S63-S68
        • Marcus D.A.
        • Kapelewski C.
        • Jacob R.G.
        • Rudy T.E.
        • Furman J.M.
        Validation of a brief nurse-administered migraine assessment tool.
        Headache. 2004; 44: 328-332
        • MacGregor E.A.
        Hormonal contraception and migraine.
        J Fam Plann Reprod Health Care. 2001; 27: 49-52
        • United States Census Bureau
        Washington quick facts.
        (Available at:) ([Retrieved July 18, 2005])
        • Mosher W.D.
        • Martinez G.M.
        • Chandra A.
        • Abma J.C.
        • Willson S.J.
        Use of contraception and use of family planning services in the United States: 1982���2002.
        Adv Data. 2004; : 1-36
        • Potts M.
        • Denny C.
        Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
        Drug Saf. 1995; 13: 333-337
        • Harrison-Woolrych M.
        • Howe J.
        • Smith C.
        Improving access to emergency contraception.
        BMJ. 2001; 322: 186-187
        • Trussell J.
        • Stewart F.
        • Potts M.
        • Guest F.
        • Ellertson C.
        Should oral contraceptives be available without prescription?.
        Am J Publ Health. 1993; 83: 1094-1098
        • Guendelman S.
        • Denny C.
        • Mauldon J.
        • Chetkovich C.
        Perceptions of hormonal contraceptive safety and side effects among low-income Latina and non-Latina women.
        Matern Child Health J. 2000; 4: 233-239
        • Miller L.
        • Nielsen C.
        Internet availability of contraceptives.
        Obstet Gynecol. 2001; 97: 121-126
        • Colditz G.A.
        • Martin P.
        • Stampfer M.J.
        • et al.
        Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.
        Am J Epidemiol. 1986; 123: 894-900
        • Goodman M.T.
        • Nomura A.M.
        • Wilkens L.R.
        • Kolonel L.N.
        Agreement between interview information and physician records on history of menopausal estrogen use.
        Am J Epidemiol. 1990; 131: 815-825
        • Boissonnault W.G.
        • Badke M.B.
        Collecting health history information: the accuracy of a patient self-administered questionnaire in an orthopedic outpatient setting.
        Phys Ther. 2005; 85: 531-543
        • Papageorghiou A.T.
        • Yu C.K.
        • Erasmus I.E.
        • Cuckle H.S.
        • Nicolaides K.H.
        Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler.
        BJOG. 2005; 112: 703-709